Investor Relations

Partnerships are integral to Harbour BioMed's strategy to build a fully integrated biopharmaceutical company.

  1. Mar 25, 2022

    2021 Annual Results Online Conference

  2. Dec 08, 2021

    201 R&D Day

  3. Sep 14, 2021

    HBM4003 Phase I Data Readout

  4. Aug 31, 2021

    2021 Interim Results Conference Call

  5. Jul 07, 2021

    HBM9161 MG Phase II Trial Topline Data Readout